Fintel reports that on November 13, 2025, BTIG reiterated coverage of Insulet (NasdaqGS:PODD) with a Buy recommendation.
Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...